This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2022 Jan;40(1):116-119.

doi: 10.2337/cd21-0042.

Combined Dipeptidyl Peptidase 4 Inhibitor and α-Glucosidase Inhibitor Treatment in Postprandial Hypoglycemia

David T Broome¹, Alimitha Kodali¹, Danielle Phillips², Vinni Makin¹, Daniel Mendlovic¹, Robert S Zimmerman¹

Affiliations

Affiliations

¹ Department of Endocrinology, Diabetes & Metabolism, Cleveland Clinic Foundation, Cleveland, OH.
² Cleveland Clinic Anesthesiology Institute, Cleveland Clinic Foundation, Cleveland, OH.

PMID: 35221483
PMCID: PMC8865782
DOI: 10.2337/cd21-0042

Case Reports

Combined Dipeptidyl Peptidase 4 Inhibitor and α-Glucosidase Inhibitor Treatment in Postprandial Hypoglycemia

David T Broome et al. Clin Diabetes. 2022 Jan.

. 2022 Jan;40(1):116-119.

doi: 10.2337/cd21-0042.

Authors

David T Broome¹, Alimitha Kodali¹, Danielle Phillips², Vinni Makin¹, Daniel Mendlovic¹, Robert S Zimmerman¹

Affiliations

¹ Department of Endocrinology, Diabetes & Metabolism, Cleveland Clinic Foundation, Cleveland, OH.
² Cleveland Clinic Anesthesiology Institute, Cleveland Clinic Foundation, Cleveland, OH.

PMID: 35221483
PMCID: PMC8865782
DOI: 10.2337/cd21-0042

No abstract available

PubMed Disclaimer

Similar articles

Comparison of efficacies of a dipeptidyl peptidase IV inhibitor and alpha-glucosidase inhibitors in oral carbohydrate and meal tolerance tests and the effects of their combination in mice.
Yamazaki K, Inoue T, Yasuda N, Sato Y, Nagakura T, Takenaka O, Clark R, Saeki T, Tanaka I. Yamazaki K, et al. J Pharmacol Sci. 2007 May;104(1):29-38. doi: 10.1254/jphs.fp0061376. Epub 2007 May 8. J Pharmacol Sci. 2007. PMID: 17485917
Cerebrovascular Complications of Diabetes: Alpha Glucosidase Inhibitor as Potential Therapy.
Patel SS. Patel SS. Horm Metab Res. 2016 Feb;48(2):83-91. doi: 10.1055/s-0035-1565181. Epub 2015 Nov 17. Horm Metab Res. 2016. PMID: 26575305 Review.
Synergistic effect of α-glucosidase inhibitors and dipeptidyl peptidase 4 inhibitor treatment.
Horikawa Y, Enya M, Iizuka K, Chen GY, Kawachi S, Suwa T, Takeda J. Horikawa Y, et al. J Diabetes Investig. 2011 Jun 5;2(3):200-3. doi: 10.1111/j.2040-1124.2010.00081.x. J Diabetes Investig. 2011. PMID: 24843484 Free PMC article.
Steroidal saponins from Trillium govanianum as α-amylase, α-glucosidase, and dipeptidyl peptidase IV inhibitory agents.
Suresh PS, Singh PP, Padwad YS, Sharma U. Suresh PS, et al. J Pharm Pharmacol. 2021 Mar 8;73(4):487-495. doi: 10.1093/jpp/rgaa038. J Pharm Pharmacol. 2021. PMID: 33793831
[Hypoglycemia in the diabetes treatment - risk minimization with dipeptidyl peptidase-4 inhibitors].
Acuña C. Acuña C. Drugs Today (Barc). 2010 Dec;46 Suppl F:1-12. Drugs Today (Barc). 2010. PMID: 21240332 Review. Spanish.

See all similar articles

References

1. Altuntaş Y. Postprandial reactive hypoglycemia. Sisli Etfal Hastan Tip Bul 2019;53:215–220 - PMC - PubMed
1. Permutt MA. Postprandiol hypoglycemia. Diabetes 1976;25:719–733 - PubMed
1. Scheen AJ, Lefèbvre PJ. Reactive hypoglycaemia, a mysterious, insidious but non dangerous critical phenomenon. Rev Med Liege 2004;59:237–242 [in French] - PubMed
1. Brun JF, Fedou C, Mercier J. Postprandial reactive hypoglycemia. Diabetes Metab 2000;26:337–351 - PubMed
1. Ozgen AG, Hamulu F, Bayraktar F, et al. . Long-term treatment with acarbose for the treatment of reactive hypoglycemia. Eat Weight Disord 1998;3:136–140 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources